RY 158.42 -2.3365% SHOP 106.88 -7.7667% TD 81.285 -1.6396% ENB 62.25 -2.5364% BN 67.38 -5.0049% TRI 240.23 -3.0471% CNQ 38.91 -7.4673% CP 100.18 0.9675% CNR 138.81 0.318% BMO 128.11 -5.3211% BNS 66.41 -2.5961% CSU 4403.5898 -2.5664% CM 80.03 -3.6248% MFC 39.89 -7.6193% ATD 71.08 -2.6568% NGT 63.19 -7.1964% TRP 65.305 -4.8864% SU 47.03 -9.261% WCN 273.28 -2.9304% L 207.78 -0.8494%
Last update at 2025-04-04T16:28:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Spartan Capital Securities, LLC Announces Key February Transactions
Fri 07 Mar 25, 09:56 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2016-12-31 |
| Income before tax | -9.54700M | -5.92578M | 2.61M | 1.62M | -4.57794M |
| Minority interest | - | - | - | - | 0.00000M |
| Net income | -9.61000M | -5.95003M | 2.35M | 1.17M | -4.57794M |
| Selling general administrative | 5.58M | 4.44M | 2.44M | 1.70M | 1.07M |
| Selling and marketing expenses | 6.81M | 4.76M | 2.42M | 0.69M | - |
| Gross profit | 11.29M | 10.52M | 8.59M | 5.85M | 0.10M |
| Reconciled depreciation | 3.37M | 1.42M | 0.80M | 0.78M | - |
| Ebit | -10.41600M | -5.35905M | 1.18M | 1.67M | -2.10945M |
| Ebitda | -7.04200M | -3.93748M | 1.98M | 2.45M | - |
| Depreciation and amortization | 3.37M | 1.42M | 0.80M | 0.78M | - |
| Non operating income net other | - | - | - | - | 0.00000M |
| Operating income | -10.41600M | -5.35905M | 1.18M | 1.67M | -1.28852M |
| Other operating expenses | 56.30M | 40.63M | 30.16M | 27.07M | 0.84M |
| Interest expense | 0.21M | 0.57M | 0.08M | 0.05M | 0.00000M |
| Tax provision | 0.06M | 0.02M | 0.26M | 0.44M | - |
| Interest income | - | - | - | - | - |
| Net interest income | -0.21200M | -0.56673M | -0.07865M | -0.05258M | -1.76298M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.46M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | 0.06M | 0.02M | 0.26M | 0.44M | 0.00000M |
| Total revenue | 45.89M | 35.27M | 31.34M | 28.74M | 0.23M |
| Total operating expenses | 21.71M | 15.88M | 7.41M | 4.18M | 1.52M |
| Cost of revenue | 34.59M | 24.75M | 22.75M | 22.89M | 0.13M |
| Total other income expense net | 0.87M | -0.56673M | 1.43M | -0.05258M | -1.52645M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | -9.61000M | -5.95003M | 2.35M | 1.17M | -4.57794M |
| Net income applicable to common shares | - | -5.95003M | 2.35M | 1.17M | -4.57794M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 10.05M | 20.76M | 24.61M | 11.11M | 8.25M |
| Intangible assets | 3.97M | 10.57M | 10.46M | 2.62M | 2.92M |
| Earning assets | - | - | - | - | - |
| Other current assets | 1.26M | 0.82M | 0.36M | 0.23M | 0.15M |
| Total liab | 9.51M | 8.38M | 8.48M | 6.78M | 6.28M |
| Total stockholder equity | 0.54M | 12.39M | 16.13M | 4.33M | 1.97M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 2.74M | 2.25M | 0.92M | 1.38M | 0.35M |
| Common stock | - | - | 0.00035M | 0.00028M | 0.00028M |
| Capital stock | 0.00000M | 0.00000M | 0.00035M | 0.00028M | 0.00028M |
| Retained earnings | -24.90500M | -12.56800M | -2.66396M | 3.29M | 0.93M |
| Other liab | - | 2.23M | 2.23M | - | 0.08M |
| Good will | 0.00000M | 1.29M | 1.29M | - | - |
| Other assets | - | 1.07M | 0.82M | 0.45M | - |
| Cash | 1.23M | 1.34M | 1.77M | 1.40M | 0.97M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 8.12M | 6.15M | 6.25M | 6.78M | 6.20M |
| Current deferred revenue | - | - | - | 0.30M | 0.75M |
| Net debt | 3.08M | 1.07M | 1.68M | -0.64830M | -0.97483M |
| Short term debt | 3.43M | 2.41M | 3.45M | 0.75M | - |
| Short long term debt | 3.43M | 2.41M | 3.28M | 0.75M | - |
| Short long term debt total | 4.32M | 2.41M | 3.45M | 0.75M | - |
| Other stockholder equity | 25.44M | 24.96M | 18.80M | 1.04M | 1.04M |
| Property plant equipment | - | 0.08M | 0.25M | 0.02M | 0.04M |
| Total current assets | 5.73M | 7.75M | 11.80M | 8.03M | 5.29M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | 4.39M | 1.71M | -0.94423M |
| Short term investments | - | - | - | - | - |
| Net receivables | 3.24M | 5.59M | 9.67M | 6.40M | 4.17M |
| Long term debt | 0.89M | - | - | - | - |
| Inventory | - | - | - | - | - |
| Accounts payable | 1.95M | 1.48M | 1.87M | 4.35M | 5.10M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 0.30M | 1.07M | 0.82M | 0.45M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4.32M | 13.01M | 12.81M | 3.08M | 2.96M |
| Capital lease obligations | 0.00000M | 0.00000M | 0.18M | - | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2016-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2016-12-31 |
| Investments | -3.31900M | -7.62876M | -0.47746M | -3.64894M | -0.00500M |
| Change to liabilities | 0.00000M | -2.47703M | -1.20164M | 3.29M | 0.51M |
| Total cashflows from investing activities | - | -7.62876M | -0.47746M | -3.64894M | -0.00500M |
| Net borrowings | 0.00900M | 1.07M | 1.64M | 1.64M | 0.95M |
| Total cash from financing activities | 5.49M | 15.29M | 1.64M | 1.64M | 0.95M |
| Change to operating activities | 0.62M | 1.62M | -0.46376M | -1.47906M | 0.00000M |
| Net income | -9.60900M | -5.95003M | 2.35M | 1.17M | -4.57794M |
| Change in cash | -0.42900M | 0.37M | 0.43M | 0.32M | -0.02387M |
| Begin period cash flow | 1.77M | 1.40M | 0.97M | 0.66M | - |
| End period cash flow | 1.34M | 1.77M | 1.40M | 0.97M | 0.66M |
| Total cash from operating activities | -2.60000M | -7.29330M | -0.73467M | 3.97M | -0.97132M |
| Issuance of capital stock | 5.89M | - | - | - | - |
| Depreciation | 3.37M | 1.42M | 0.80M | 0.78M | 0.71M |
| Other cashflows from investing activities | - | - | - | - | 0.00000M |
| Dividends paid | - | - | - | - | 0.00000M |
| Change to inventory | - | 2477.03M | - | - | 0.00000M |
| Change to account receivables | 4.08M | -3.27628M | -2.22591M | 0.21M | 0.00000M |
| Sale purchase of stock | -0.14200M | - | - | - | 0.00000M |
| Other cashflows from financing activities | -0.06200M | -1128.57709M | -0.47746M | -3.64894M | 0.00000M |
| Change to netincome | -0.67000M | 1.37M | 1.37M | 1.37M | 1.54M |
| Capital expenditures | 3.32M | 3.13M | 0.48M | 3.65M | 0.00500M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | 4.31M | -3.95059M | -3.89131M | 2.02M | - |
| Stock based compensation | 0.26M | 0.05M | - | - | - |
| Other non cash items | -0.92800M | 1.08M | -6.04664M | - | - |
| Free cash flow | -5.91900M | -10.42206M | -1.21213M | 0.32M | - |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCTI Healthcare Triangle Inc |
-0.0044 1.91% | 0.23 | - | - | 0.18 | 10.98 | 0.27 | -2.1902 |
| GEHC GE HealthCare Technologies Inc. |
-9.225 12.81% | 62.77 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-8.745 3.95% | 212.75 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.45 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.27 5.03% | 5.10 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, the company offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. It primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. The company was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. operates as a subsidiary of SecureKloud Technologies, Inc.
7901 Stoneridge Drive, Pleasanton, CA, United States, 94588
| Name | Title | Year Born |
|---|---|---|
| Mr. Suresh Venkatachari | Chairman, Pres & CEO | 1967 |
| Mr. Anand Kumar | Sr. VP & Head of Cloud Solutions | 1974 |
| Mr. Sudish Mogli | Consultant | 1969 |
| Mr. Michael Gill | VP of Fin. | 1978 |
| Mr. Thyagarajan Ramachandran | Chief Financial Officer | 1976 |
| Mr. Michael Campana | VP of Marketing | NA |
| Ms. Kristi Lane | VP of HR & Talent Management | NA |
| Mr. Shibu Kizhakevilayil | Head of M&A and Director | 1972 |
| Mr. Lakshmanan Kannappan | Head of Strategic Partnerships & Director | 1967 |
| Mr. Anand Kumar | Chief Revenue Officer & Interim CEO | 1975 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA
AU
UK
US
NZ
IND
Please wait processing your request...